Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Monotherapy vs Quetiapine + Sodium Valproate in Non-responding Acute Mania
2005-000211-99Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of quetiapine and Orfiril Long in bipolar disorder (BD) (3 arms), sponsored by AstraZeneca. Started Feb 2005; status: completed.
02
Drugs
quetiapineOrfiril Long
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2005-000211-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000211-99.